Healthcare
Capricorn invests in C-Lecta
Capricorn draws capital for the investment from Capricorn Sustainable Chemistry Fund
Healthcare under observation among European GPs
Digitalisation and vendors that are increasingly receptive to PE are providing opportunities in the sector
Star Capital buys Educom via DPH
Educom will be owned by DPH, a company established by Star to pursue its buy-and-build strategy
ADV leads £3m series-A for Healthera
Previous backer Cambridge Enterprise and newcomer Future Care Capital also take part in the funding
WCAS takes Abzena private for £34.4m
Biotechnology and pharmaceutical company has previously received backing from a number of VCs
Catapult, Mercia in funding round for Rinicare
NPIF - Mercia Equity Finance is part of the Northern Powerhouse Investment Fund
H2 buys Healthcare 21
GP plans to merge the two companies and create a combined group with operations across Europe
VC firms invest £2.4m in BioBeats
IQ Capital, Oxford Sciences Innovation and White Cloud Capital lead the round
VC-backed Orchard Therapeutics raises $150m series-C
UK-based biotechnology company is registering and launching three treatments for rare disorders
Connect leads $3m round for OurPath
Connected healthcare programme is designed to help type 2 diabetese patients reverse the disease
Andera and LSP lead $84m series-B for Artios
Biotech firm will undertake clinical proof-of-concept trials for its DNA polymerase theta programme
Therachon nets $60m mezzanine from Novo et al.
Existing investors Versant Ventures, OrbiMed, BPI France and Inserm Transfert Initiative also take part
Nordic Capital acquires Excent Tandtechniek
Deal was made as an add-on to Nordic Capital's European Dental Group platform
H2 acquires Aquilant from UDG for up to €23m
Deal for the healthcare products and services provider will see the GP pay тЌ20.5m up front
Paragon buys Innere Medizin from UCB
Paragon draws equity from its €412m buyout fund, which held a final close in 2017
VC firms back $55m series-B for ReViral
Round is led by New Leaf Venture Partners and Novo Ventures, alongside new and existing investors
3i-backed Ponroy buys Densmore
Second bolt-on the group has made since 3i's initial buyout of the business in 2016
CapVest targets €1bn for fourth fund
Vehicle is a significant increase on CapVest Equity Partners III, which closed on тЌ482m
BDC to exit dental imaging company Acteon
Acteon was the second investment in France made by Bridgepoint Development Capital II
CareVentures holds first close on €60m
Vehicle was registered in Luxembourg as CareVentures Fund II SCSP in April this year
GED's Vitro bolts on Cytognos
Following the acquisition, the combined group expects to reach sales of around €25m in 2018
Balderton leads $10m series-A for HealX
Drug repurposing company will more than double its headcount and invest in product development
CapDecisif holds first close for CapDecisif 4
VC is aiming to exceed its €50m target but will not surpass the €70m assigned hard-cap
ADV leads $8m round for Snap40
UK-based growth and venture capital firm MMC Ventures is also participating in the funding round